BIO Announces NSF Track featuring 10 emerging biotech companies.
Share:
Press Release Summary:
BIO's announced agreement with National Science Foundation (NSF) to bring SBIR-funded, early-stage biotech companies to present at BIO Investor Forum 2013. Presenting companies in NSF track include ADMdx, Biodesy, Carmot, CertiChem, Jade Therapeutics, Nano3D Biosciences, Nanofiber Solutions, Parabon Nanolabs, Stemina, and Tymora Analytical Operations. All are funded by NSF and focused on drug discovery, diagnostics, and other platform technologies.
Original Press Release:
BIO Announces National Science Foundation Track Featuring 10 Emerging Biotech Companies at 12th Annual BIO Investor Forum
NSF-funded companies focused on drug discovery, diagnostics and other platform technologies
BIO Investor Forum 2013
BIO Investor Forum 2013:Biotechnology Industry Organization (BIO)
WASHINGTON--The Biotechnology Industry Organization (BIO) today announced an agreement with the National Science Foundation (NSF) to bring SBIR-funded early-stage biotech companies to present at the 12th Annual BIO Investor Forum. The companies, funded by NSF and focused on drug discovery, diagnostics and other platform technologies, will participate in a dedicated track of company presentations.
“These connections will be invaluable as our companies build on their early successes and move forward in bringing innovative technologies to market, where they will ultimately help to stimulate the U.S. economy and improve lives.”
“We are pleased to work with the National Science Foundation to offer this track of company presentations to BIO Investor Forum attendees,” said Jim Greenwood, BIO’s President & CEO. “Through the NSF grant program, these companies have demonstrated significant market potential and transformational technology with substantial societal impact, presenting an incredible investment opportunity for early-stage investors.”
“The BIO Investor Forum is an opportunity for NSF-funded companies to form long-term partnerships and begin to raise funds in the private sector,” said Jesus Soriano, MD, PhD, MBA, NSF program director for Small Business Innovation Research (SBIR). “These connections will be invaluable as our companies build on their early successes and move forward in bringing innovative technologies to market, where they will ultimately help to stimulate the U.S. economy and improve lives.”
Presenting companies in the NSF track include:
ADMdx – Diagnostics Platform (Neuroimaging)
Biodesy – Drug Discovery Platform (In Silico)
Carmot – Drug Discovery Platform (Chemotype Evolution)
CertiChem – Assay Platform (Estrogenic Activity in vitro, & in vivo)
Jade Therapeutics - Drug Delivery Platform (Ophthalmology, Biologics)
Nano3D Biosciences – Assay Platform (3-D Cell Activity)
Nanofiber Solutions – Assay Platform (3-D Cell Scaffolds & Tissue Engineering)
Parabon Nanolabs – Drug Discovery Platform & Forensics
Stemina – Biomarker Discovery
Tymora Analytical Operations – Assay Platform (Phosphorylation Analyses)
Each of the companies has been rigorously vetted through the NSF review process to receive Small Business Innovation Research (SBIR) grant funding. The majority of the presenting companies have received SBIR Phase II grants.
The BIO Investor Forum features public and venture-stage company presentations, expert-led business roundtables, one-on-one investor meetings and networking opportunities.
To learn more about the BIO Investor Forum, including registration and program information, please visit here. Advance media registration is available here. Registration is complimentary for credentialed members of the media and qualified investors.
BIO is pleased to recognize the leadership provided by the BIO Investor Forum Conference sponsors including our Local Co-Host BayBio and Supporting Banks: Canaccord Genuity, Piper Jaffray and Roth Capital Partners. BIO Double Helix and Helix Sponsors include AbbVie, Amgen, Baxter, Janssen, and Merck. Conference supporters include Blaise Group International, Bristol-Myers Squibb, Chubb, Dectiva, Dentons, Fenwick & West LLP, Knobbe Martens, LaVoie Group, MacDougall Biomedical Communications and SecureDocs.
About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.
Upcoming BIO Events
BIO Investor Forum
October 8-9, 2013
San Francisco, CA
BIO IPCC Conference
November 6-8, 2013
Washington, DC
BIO Convention in China
November 11-13, 2013
Beijing, China
Pacific Rim Summit on Industrial Biotechnology & Bioenergy
December 8-11, 2013
San Diego, CA
BIO CEO & Investor Conference
February 10 – 11, 2014
New York, NY
BIO Asia International Conference
April 8-9, 2014
Tokyo, Japan
World Congress on Industrial Biotechnology
May 12-15, 2014
Philadelphia, PA
BIO International Convention
June 23-26, 2014
San Diego, CA
Contacts
Biotechnology Industry Organization (BIO)
Daniel Seaton, 202-470-5207
Web: www.bio.org
Blog: www.biotech-now.org
Twitter: @IAmBiotech
